(-)-Epigallocatechin Gallate

For research use only.

Catalog No.S2250 Synonyms: EGCG

22 publications

(-)-Epigallocatechin Gallate Chemical Structure

CAS No. 989-51-5

(-)-Epigallocatechin Gallate(EGCG) is the main catechin extraction of green tea that inhibits telomerase and DNA methyltransferase. EGCG blocks the activation of EGF receptors and HER-2 receptors. ECGG inhibits fatty acid synthase and glutamate dehydrogenase activity.

Size Price Stock Quantity  
10mM (1mL in DMSO) USD 201 In stock
USD 99 In stock
USD 149 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Selleck's (-)-Epigallocatechin Gallate has been cited by 22 publications

Purity & Quality Control

Choose Selective Telomerase Inhibitors

Biological Activity

Description (-)-Epigallocatechin Gallate(EGCG) is the main catechin extraction of green tea that inhibits telomerase and DNA methyltransferase. EGCG blocks the activation of EGF receptors and HER-2 receptors. ECGG inhibits fatty acid synthase and glutamate dehydrogenase activity.
Targets
telomerase [4]
()
DNMT [4]
()
HER2 [5]
()
EGFR [5]
()
FASN [6]
()
In vitro

(-)-Epigallocatechin gallate functions as a powerful antioxidant, preventing oxidative damage in healthy cells, but also as an antiangiogenic and antitumor agent and as a modulator of tumor cell response to chemotherapy. (-)-Epigallocatechin gallate shows multiple anticancer effects, such as anti-proliferation, anti-angiogenesis, transformation prevention of various cancer cells, cancer cell cycle arrest and inhibition of tumor metastasis. (-)-Epigallocatechin gallate exerts multi-anticancer effects through regulating several cancer-related cell signal pathways (regulated the function or the expression of key signal proteins, such as nuclear factor-κB, MAPKs and activator protein-1, EGFR, IGF, COX-2 signaling pathway, and so on.), effecting methylation of cancer genes and combination of ligand with membrane receptors. [1] (-)-Epigallocatechin gallate also shows an immunomodulating effects. Several types of immune cells in both the innate and adaptive immune systems are known to be affected in varying degrees by (-)-Epigallocatechin gallate. Among them, the dramatic effect on T cell functions has been repeatedly demonstrated, including T cell activation, proliferation, differentiation, and production of cytokines. Studies using animal models of autoimmune diseases have reported disease improvement in animals treated with green tea/EGCG. [2] (-)-Epigallocatechin gallate displays anti-infective properties. Antiviral activities of (-)-Epigallocatechin gallate with different modes of action have been demonstrated on diverse families of viruses, such as Retroviridae, Orthomyxoviridae and Flaviviridae and include important human pathogens like human immunodeficiency virus, influenza A virus and the hepatitis C virus. [3]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
SH-SY5Y cells MnvTSpVv[3Srb36gZZN{[Xl? M1LqdG5mfXKxcILveIVkfGmxbjDh[4FqdnO2IHLleIEu[W27bH;p[EBx\XC2aXTlJFEuPDJvaX7keYNm\CC2b4jpZ4l1gSCrbjDoeY1idiCVSD3TXVV[KGOnbHzzJIF{e2W|c3XkJIF{KGyjY4TheIUh\GWqeXTyc4dmdmG|ZTDy[Yxm[XOnLDDFR|UxRTBwMEO5PFch|ryP NYD0e29JOTlzM{i4OVk>
human MDA435/LCC6MDR cells MmnHSpVv[3Srb36gZZN{[Xl? NVu4[XRmOTBizszN NFTwS|g2KGSjeYO= Mn3tUY9lfWyjdHnvckBw\iCSLXfwJEh2dmuwb4fuJI9zcWerbjmgeJJidnOoZXP0[YQhcW5iaIXtZY4hVUSDNEO1M2xESz[PRGKgZ4VtdHNiYYPz[ZN{\WRiYYOgdoV3\XK|aXLs[UBw\iCyYXPsbZRigGWuIILld4l{fGGwY3WgcYVie3W{ZXSgZZMhUUN3MDDmc5IheGGlbHn0ZZhmdCCjdDCxNEB2VSCjZoTldkA2KGSjeYOgZpkhS2WubGTpeIVzKDl4IFHxeYVwfXNiYYPzZZktKEmFNUC9NE4yOjJ4IN88US=> NEPGdJEzPTl6NUG5OS=>
Sf9 cells NET6d|VHfW6ldHnvckBie3OjeR?= NX\oZXFCUW6qaXLpeIlwdiCxZjDIbZM3NXSjZ3fl[EBpfW2jbjDy[YNwdWKrbnHueEBFVk2WMTDlfJBz\XO|ZXSgbY4hcW6|ZXP0JHNnQSClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6gSG5CKG2ndHj5cJRz[W6|ZnXyZZNmKGGldHn2bZR6KHW|aX7nJFUoNWKrb4Tpcplt[XSnZDC0OU1jeCC3bn3leIh6dGG2ZXSgc5IhcGWvaX3leIh6dGG2ZXSgc4xq\2:wdXPs[Y91cWSnIIP1ZpN1emG2ZYOgZY5lKFt|SG2tRYRwVWW2IHL5JIxqeXWrZDDzZ4lvfGmubHH0bY9vKGOxdX70bY5oKG2ndHjv[EwhUUN3ME2wMlUh|ryP MY[yOVQxPjl2NB?=
human U937 cells M1jFVGZ2dmO2aX;uJIF{e2G7 NGrpOmRKdmirYnn0bY9vKG:oIITlcI9u\XKjc3WgbY4hcHWvYX6gWVk{PyClZXzsd{whUUN3ME2xJO69VQ>? M1L5VlIzPDF|OES1
human HeLa cells NHLsUVRHfW6ldHnvckBie3OjeR?= NELBWmFKdmirYnn0bY9vKG:oIITlcI9u\XKjc3WgbY4hcHWvYX6gTIVN[SClZXzsd{B2e2mwZzC1K{1CSVRiQ1PHJHRETyCDR1OgRWdCKEeWVD2zK{BieyC|dXLzeJJifGViaX7jeYJifGWmIH\vdkAyPSCvaX7zJJBzcW:{IITvJIV5fGWwc3nvckBz\WGldHnvckBnd2yub4fl[EBjgSClb33wc5Vv\CC5YYPoc5V1KGK7IIPwbY4ufGWub33ldolkKHKncHXheEBidXCuaX\pZ4F1cW:wIIDyc5Rw[2:uLDDJR|UxRTFwMEig{txO MXiyNlQyOzh2NR?=
CHO cells NV7sRm95S3m2b4TvfIlkyqCjc4PhfS=> NX[yUI5kPDhiaB?= Ml62R5l1d3SxeHnjbZR6KGGpYXnud5QhS0iRIHPlcIx{KGW6cILld5NqdmdiT1HUVFFDOyCqYYDsc5R6eGViMTDh[pRmeiB2ODDodpMh[nliZnz1c5Jme2OnbnPlJIJie2WmIFPlcIxVcXSncj3HcI8h[XO|YYmsJGlEPTB;Mz6yJO69VQ>? M2fsVVI{OzJ5OEe3
MDCK cells NHvqd25HfW6ldHnvckBie3OjeR?= Mn7LOEBl[Xm| M3O1fmFvfGm4aYLhcEBi[3Srdnn0fUBi\2GrboP0JIlv\my3ZX76ZUBCKH[rcoXzJEhCN3O5aX7lM29JNzVzMUS0OU8zODB5KFixUlEqMSCRaEegbY5n\WO2ZXSgbY4hVUSFSzDj[YxteyCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKH[rcnHsJJJmeGyrY3H0bY9vKGGodHXyJFQh\GG7czDifUByfWGwdHn0ZZRqfmViUmStVGNTNCCHREWwQVgvOyEQvF2= Ml7sNlIyOTV3OUG=
human HL60 cells NIG0Z49Rem:uaX\ldoF1cW:wIHHzd4F6 M{X4RlMh\GG7cx?= M{K1WWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iSFy2NEBk\WyuczDh[pRmeiB|IHThfZMtKEmFNUC9PU41KM7:TR?= NEXjSpYyQDZ7M{CyNC=>
HSC-T6 cells  MV\GeY5kfGmxbjDhd5NigQ>? MlfOOFghcA>? MkS4RY51cW[rYoLveIlkKGGldHn2bZR6KGGpYXnud5QhemG2IFjTR{1VPiClZXzsd{Bie3Onc4Pl[EBieyCrbnjpZol1cW:wIH;mJJBzd2yrZnXyZZRqd25iYX\0[ZIhPDhiaILzJIJ6KEK{ZGWgbY5kd3Kyb4LheIlwdiCjc4PhfUwhUUN3ME25Mlkh|ryP NGe5fGEzOTVyNEi0PC=>
mouse 3T3-L1 cells MV3GeY5kfGmxbjDhd5NigQ>? MmfkTY5pcWKrdHnvckBw\iCJNmDEMY1m\GmjdHXkJG5CTFCKIIDyc4R2[3Srb36gbY4hdW:3c3WgN3Q{NUxzIHPlcIx{NCCLQ{WwQVI2KM7:TR?= NGTqVXoyQDNzM{OwPC=>
mouse RAW264.7 cells Mlf2SpVv[3Srb36gZZN{[Xl? M3rkU|Uh\GG7cx?= NXjmWm5LUW6qaXLpeIlwdiCxZjDSRW5MVC2rbnT1Z4VlKG:|dHXvZ4xie3SxZ3Xu[ZNqeyCrbjDtc5V{\SCUQWeyOlQvPyClZXzsd{Bie3Onc4Pl[EBieyCmZXPy[YF{\SCrbjDUVmFRNXCxc3n0bZZmKG23bITpMY52[2ynYYTl[EBk\WyuczDh[pRmeiB3IHThfZMtKEmFNUC9NlkvQCEQvF2= M{XESVIyPDV4NUKx
HSC-T6 cells M4jpRXBzd2yrZnXyZZRqd25iYYPzZZk> MVzBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IILheEBJW0NvVE[gZ4VtdHNiYYPz[ZN{\WRiYYOgdoVlfWO2aX;uJIlvKGOnbHygeoli[mmuaYT5MEBKSzVyPUK5Mlgh|ryP MUWyOVMzOjR3NR?=
human A431 cells M4C5U3Bzd2yrZnXyZZRqd25iYYPzZZk> M4rhfFQ5KGh? MmjIRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCDNEOxJINmdGy|IH;2[ZJmgHC{ZYPzbY5oKEW{YlKgbY4he2W{dX2t[pJm\SCvZXTpeY0h[XO|ZYPz[YQh[XNiY3XscEB3cWGkaXzpeJkh[W[2ZYKgOFghcHK|IHL5JHdUXC1zIHHzd4F6NCCHQ{WwQVM5KM7:TR?= MYGyOFQ2PjByNB?=
human MDA-MB-231 cells MVrQdo9tcW[ncnH0bY9vKGG|c3H5 NXv6b4FKOjRiaB?= NELNfoZCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3ERU1OSi1{M{GgZ4VtdHNiYX\0[ZIhOjRiaILzJIJ6KE2WVDDhd5NigQ>? M2PtbVIzPDV7MkC4
human HepG2 cells NYjNUYVNTnWwY4Tpc44h[XO|YYm= M{H6XFI1KGh? NUXwRWtJUW6qaXLpeIlwdiCxZjDvcIVq[yCjY3nkMYlv\HWlZXSgeJJq\2y7Y3XybYRmKG:4ZYKtZYNkfW23bHH0bY9vKGmwIHj1cYFvKEincFeyJINmdGy|IHnuZ5Vj[XSnZDDmc5IhOjRiaILzJJJmdGG2aY\lJJRwKHWwdILlZZRm\CClb370do9t M1HNWlIyQDJ2Nkmw
human HepG2 cells MlO1SpVv[3Srb36gZZN{[Xl? M2TQU|I1KGh? M1TnTGFvfGmxeHnkZY51KGGldHn2bZR6KGmwIHj1cYFvKEincFeyJINmdGy|IHHzd4V{e2WmIHHzJJJm\HWldHnvckBw\iCxbHXpZ{Bi[2mmLXnu[JVk\WRiUl;TJIdmdmW{YYTpc44hcW6ldXLheIVlKG[xcjCyOEBpenNiYomgSGhETi2GQTDiZZNm\CCobIXvdolu\XS{aXOgZZN{[XlicnXsZZRqfmVidH:geY51emWjdHXkJINwdnS{b3y= MX6yNVgzPDZ7MB?=
human Caco-2 cells MXLHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? NIK5c3kzPSEQvF2= M3LW[FYh\GG7cx?= M{LN[2dzd3e2aDDpcohq[mm2aX;uJI9nKGi3bXHuJGNi[29vMjDj[YxteyCjdDCyOUB2VSCjZoTldkA3KGSjeYO= NUXWW4ZlOTh|MkS3OlM>
mouse 3T3 cells MlnKSpVv[3Srb36gZZN{[Xl? M{jkRlEuOjBizszN M3LWflEzKGh? NVnIfGJDSW62aX3p[5JifG:{eTDhZ5Rqfmm2eTDh[4FqdnO2IGP3bZN{KGGuYnnuc{Bud3W|ZTCzWFMh[2WubIOgZZN{\XO|ZXSgZZMhcW6lcnXhd4Uhd2ZiY3XscEBvfW2kZYLzJIF1KDFidH:gNlAhfU1iYX\0[ZIhOTJiaILzJIJ6KGK7IIPjdoF1[2hvd3;1coQh[XO|YYm= MWWyNVA5ODZ2Mh?=
human MDA-MB-231 cells NWPpS4RbWHKxbHnm[ZJifGmxbjDhd5NigQ>? MlW4NlQhcA>? MUPBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKE2GQT3NRk0zOzFiY3XscJMh[W[2ZYKgNlQhcHK|IHL5JG1VXCCjc4PhfS=> MVyyNlQ2QTJyOB?=
human Jurkat cells M1TFZmZ2dmO2aX;uJIF{e2G7 MnK1NVAuPTVizszN NU[5SWR2OjRiaB?= MoP1TY5pcWKrdHnvckBw\iCWTl\hcJBp[S2rbnT1Z4VlKE6ILXvhdJBiSiCjY4TpeoF1cW:wIHnuJIh2dWGwIFr1dotifCClZXzsd{BifCBzMDD0c{A2PSC3TTDh[pRmeiB{NDDodpMh[nliZXzlZ5Rzd3Cqb4LleIlkKG2xYnnsbZR6KHOqaX\0JIF{e2G7 NU\5UIJYOjFyOEC2OFI>
human K562 cells NYPRcGU6TnWwY4Tpc44h[XO|YYm= NH3meVUzPCCq MUPJcoR2[3Srb36gc4YhPjdia1ThJIxidWmwaX6gdoVk\XC2b4Kg[ZhxemW|c3nvckBqdiCqdX3hckBMPTZ{IHPlcIx{KGGodHXyJFI1KGi{czDifUBndG:5IHP5eI9u\XS{eTDhcoFtgXOrcx?= MV2yNVQ{PDZyMx?=
human HL60 cells MXrGeY5kfGmxbjDhd5NigQ>? NF7WfnMzPCCq MWPJcoR2[3Srb36gc4YhPjdia1ThJIxidWmwaX6gdoVk\XC2b4Kg[ZhxemW|c3nvckBqdiCqdX3hckBJVDZyIHPlcIx{KGGodHXyJFI1KGi{czDifUBndG:5IHP5eI9u\XS{eTDhcoFtgXOrcx?= NWTZeok4OjF2M{S2NFM>
human Raji cells M2TobWdzd3e2aDDpcohq[mm2aX;uJIF{e2G7 MWGxNEDPxE1? M1fjcVQ5KGh? M1rINmdzd3e2aDDpcohq[mm2aX;uJIFo[Wmwc4SgbJVu[W5iUnHqbUBk\WyuczDhd5Nme3OnZDDhd{Bk\WyuII\pZYJqdGm2eTDheEAyOCC3TTDh[pRmeiB2ODDodpMh[nlidIL5dIFvKGKudXWgZoF{\WRibXnjdo9{[2:yaXOgZY5idHm|aYOgbY4heHKnc3XuZ4Uhd2Zic4Xw[ZJwgGmmZTDkbZNufXSjc3W= MluyNlE1OzR4MEO=
human PC3 cells MY\Qdo9tcW[ncnH0bY9vKGG|c3H5 M1vGSVExNTFyMDFOwG0> NYOybXFJPDhiaB?= M4fJZmFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iUFOzJINmdGy|IHH0JFExKHSxIEGwNEB2VSCjZoTldkA1QCCqcoOgZpkhcGWvb3P5eI9u\XS{aXOgZ4VtdCClb4XueIlv\yCvZYToc4Q> M4fEdlI{QDZ5MU[3
human A431 cells M1j2NGZ2dmO2aX;uJIF{e2G7 NGH0docyODBizszN MUmxNkBp MmrnVoVlfWO2aX;uJI9nKGOudYP0[ZJqdmdib3[gS2ZRNUeSSTDpckBtcXCrZDDyZYZ1eyCxZjDoeY1idiCDNEOxJINmdGy|IHH0JFExOCC3TTDh[pRmeiBzMjDodpMh[nliY3;u[o9k[WxibXnjdo9{[2:yaXOgZY5idHm|aYO= M3fzWlI1PDV4MEC0
human SKBR3 cells M2P1ZWZ2dmO2aX;uJIF{e2G7 NV\lWWZqOjByzszN M1Ttd|MxKG2rboO= NUHnfnpDTG:5boLl[5Vt[XSrb36gc4YhTXKkQkKgdJJwfGWrbjDlfJBz\XO|aX;uJIlvKGi3bXHuJHNMSlJ|IHPlcIx{KGmwIIPldpVuKG[{ZXWgcYVlcXWvIHH0JFIxOCC3TTDh[pRmeiB|MDDtbY5{KGK7IHntcZVvd2[udX;y[ZNk\W6lZTDzeIFqdmmwZz3iZZNm\CClb37mc4NidCCvaXPyc5Nkd3CrYzDhcoFtgXOrcx?= NXn4UFNGOjR2NU[wNFQ>
human 293T cells MXHGeY5kfGmxbjDhd5NigQ>? MWW1NEDPxE1? NGnD[mwyOiCq M1TNeWlvcGmkaYTpc44hd2ZiRGnST|FCKGmwIHj1cYFvKDJ7M2SgZ4VtdHNiYYPz[ZN{\WRiYYOgdoVlfWO2aX;uJI9nKEeOSUGgeJJidnOlcnnweIlwdiCjY4Tpeol1gSCjdDC1NEB2VSCjZoTldkAyOiCqcoOgZpkh\HWjbD3seYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZk> MnnONlIyPTR4NkS=

... Click to View More Cell Line Experimental Data

Assay
Methods Test Index PMID
Western blot
Notch1 / Notch2 ; 

PubMed: 28443100     


Human primary macrophages derived from peripheral blood mononuclear cells (PBMCs) cultured with autologous serum were pretreated with EGCG (50 μg/mL) for 30 min and exposed to LPS (200 EU/mL) for 3 h. Cell lysates from time course experiments of EGCG treatment were analyzed by western blotting and probed with a Notch1/2 antibody  

p-MAPK / MAPK ; 

PubMed: 30233784     


Effects of EGCG on IGF-I-induced phosphorylation of (A) p44/p42 MAP kinase in MC3T3-E1 cells. The cells were pretreated with various doses of EGCG for 60 min, and then stimulated by 10 nM IGF-I or vehicle for (A) 5 min. Western blot analysis was performed using antibodies against phospho-p44/p42 MAP kinase, p44/p42 MAP kinase. The histograms show quantitative representation of the levels of IGF-I-induced phosphorylation determined from laser densitometric analysis of three independent experiments. EGCG, (−)-epigallocatechin gallate; IGF-I, insulin-like growth factor-I; MAP, mitogen-activated protein.

β-catenin / p-AKT / Cyclin D1; 

PubMed: 28693189     


EGCG inhibits β-catenin, p-Akt and cyclin D1 expression in MDA-MB-231 cells. MDA-MB-231 cells were treated with EGCG for 24 h. (A) β-catenin protein expression was analyzed by western blotting. (B) p-Akt and cyclin D1 protein expression were analyzed by western blotting. β-actin was used as a loading control. Each value represents the mean ± standard error of the mean of three independent experiments. EGCG, epigallocatechin gallate; p-, phosphorylated.

28443100 30233784 28693189
Growth inhibiton assay
Cell viability; 

PubMed: 28693189     


Effect of EGCG on the viability of MDA-MB-231 cells. MDA-MB-231 cells were treated with various concentrations of EGCG for 24 h. MTT assay was used to detect the viability of the cells. The optical density value of the untreated cells was regarded as 100%. Each value represents the mean ± standard error of the mean of three independent experiments. EGCG, epigallocatechin gallate.

Cell proliferation ; 

PubMed: 23525843     


The percent EGCG that inhibits the proliferation of colorectal cancer cells at different concentrations. Notes: The x-axis and y-axis are the time after treatment and percentage of EGCG that inhibits the proliferation of colorectal cancer cells at different concentrations. Eight experiments were performed for each treatment, and the inhibition rate of cell proliferation was tested for, using a single factor analysis of variance. Abbreviation: EGCG, epigallocatechin gallate; h, hour.

28693189 23525843

Protocol

Solubility (25°C)

In vitro Ethanol 83 mg/mL warmed (181.07 mM)
DMSO 72 mg/mL warmed (157.07 mM)
Water 23 mg/mL warmed (50.17 mM)

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 458.37
Formula

C22H18O11

CAS No. 989-51-5
Storage powder
in solvent
Synonyms EGCG
Smiles C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation ()
% DMSO % % Tween 80 % ddH2O
CalculateReset

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT03928847 Recruiting Drug: Epigallocatechin-3-gallate (EGCG) Idiopathic Pulmonary Fibrosis University of California San Francisco|National Heart Lung and Blood Institute (NHLBI) July 1 2018 Early Phase 1
NCT02577393 Enrolling by invitation Drug: EGCG|Drug: mLDG Lung Neoplasms|Esophagitis|Prevention & Control|Epigallocatechin Gallate Shandong Cancer Hospital and Institute April 2015 Phase 2
NCT02580279 Unknown status Drug: EGCG|Drug: placebo Breast Neoplasms|Dermatitis|Prevention & Control|Epigallocatechin Gallate Shandong Cancer Hospital and Institute December 2014 Phase 2

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Telomerase Signaling Pathway Map

Related Telomerase Products

Tags: buy (-)-Epigallocatechin Gallate | (-)-Epigallocatechin Gallate supplier | purchase (-)-Epigallocatechin Gallate | (-)-Epigallocatechin Gallate cost | (-)-Epigallocatechin Gallate manufacturer | order (-)-Epigallocatechin Gallate | (-)-Epigallocatechin Gallate distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID